UK SBS PregnAnZI-2 doubleblind clinical trial pharmaceuticals
key details
| Value | £36,835 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | London |
| Deadline | 3 Mar 2017 |
| Contract start | 6 Mar 2017 |
| Contract end | 8 May 2017 |
| Procedure | limited |
| SME suitable | Yes |
| OCID | ocds-b5fd17-2f79d5ba-0ff7-4155-9351-e927f9cde5ea |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| Idifarma Desarrollo Farmaceutico SL | £36,835 | 3 Mar 2017 | active |
description
PregnAnZi-2 is a follow on from a smaller batch trial (PregnAnZi-1) which involved 829 patients. The new trial will involve ca. 12,500.
This supplier provided the azithromycin and placebo blisters for the previous trial and therefore it is a requirement to use them again for this expanded trial.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 3 Mar 2017 | Award (award) | · | 0697e3ea-2b25-41a5-8182-c93ca1f06875-133509 |
more from UK SHARED BUSINESS SERVICES LIMITED
- ACAS27482 - MH Good Practice tender · £69,730 · 29 Jul 2026
- CSP26511 - Finance Analyst · £8,319 · 29 Jul 2026
- CSP26493 - Employee Assistance Programme (EAP) · £100,000 · 29 Jul 2026
- CSP26614 - Infrastructure Support Analyst · £13,158 · 29 Jul 2026
- DDaT26031 - Load Balancing Software Licences · £73,425 · 28 Jul 2026
- PS26168 - Audit of internet services · £200,000 · 28 Jul 2026
- DDaT26377 - Financial Records Archive Environment · £26,719 · 27 Jul 2026
- CSP26704 - Workday Business Analyst · £111,150 · 27 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.